References
- Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012;55:1577-96. https://doi.org/10.1007/s00125-012-2534-0
- Statistics Korea: 2016 statistical results about cause of death. Available at http://www.index.go.kr. Accessed July 03, 2018.
- Korbel L, Spencer JD. Diabetes mellitus and infection: an evaluation of hospital utilization and management costs in the United States. Journal of diabetes and its complications 2015;29:192-5. https://doi.org/10.1016/j.jdiacomp.2014.11.005
- Peleg AY et al. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes/metabolism research and reviews 2007;23:3-13. https://doi.org/10.1002/dmrr.682
- Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). Pathogens and Disease 1999;26:256-65.
- Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281-8. https://doi.org/10.1086/431587
- Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab 2012; 16(Suppl1):S27-36. https://doi.org/10.4103/2230-8210.94253
- Lee YS, Lee JS, Lee SH. Analysis of drug interaction information. Korean J Clin Pharm 2009;19:1-17.
- Samardzic I, Bacic-Vrca V. Incidence of potential drug-drug interactions with antidiabetic drugs. Pharmazie 2015;70:410-5.
- Triplitt C. Drug Interactions of Medications Commonly Used in Diabetes. Diabetes Spectrum 2006;19:202-11. https://doi.org/10.2337/diaspect.19.4.202
- Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300. https://doi.org/10.1093/ageing/21.4.294
- Lee J, Lee JS, Park SH, et al. Cohort Profile: The national health insurance service-national sample cohort (NHIS-NSC), South Korea. Int J Epidemiol 2017;46:e15.
- Lexicomp. Drugs interactions. Wolters Kluwer Health, Philadelphia, Pennsylvania, USA., 2018. Available from http://www.lexi.com/ online. Accessed July 03, 2018.
- MicroMedex Truven Health Analytics. Micromedex 2.0: Drug interactions (electronic version). Greenwood Village, Colorado, USA, 2018. Available from http://www.micromedexsolutions.com. Accessed July 03, 2018.
- Tan A, Holmes HM, Kuo YF, et al. Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use. J Gerontol A Biol Sci Med Sci 2015;70(2):247-54. https://doi.org/10.1093/gerona/glu072
- Parekh TM, Raji M, Lin YL, et al. Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas. JAMA Intern Med 2014;174(10):1605-12. https://doi.org/10.1001/jamainternmed.2014.3293
- Carr R, Zed PJ. Octreotide for sulfonylurea-induced hypoglycemia following overdose. Ann Pharmacother 2002;36(11):1727-32. https://doi.org/10.1345/aph.1C076
- Frothingham R. Glucose homeostasis abnormalities associated with use of gatifloxacin. Clin Infect Dis 2005;41(9):1269-76. https://doi.org/10.1086/496929
- Gajjar DA et al. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy 2000;20(6 Pt 2):76S-86S. https://doi.org/10.1592/phco.20.8.76S.35182
- Park-Wyllie LY et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006;354(13):1352-61. https://doi.org/10.1056/NEJMoa055191
- Product Information: TEQUIN(R) (gatifloxacin) Tablets, Injection (2004), Bristol-Myers Squibb Company Princeton, NJ 08543 USA , Available from https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21061s023,024,21062s026,037lbl.pdf. Accessed August 13, 2018.
- Hong EG. Drug Therapy of Elderly Diabetic Patients. Korean J Med 2011;80:635-42.
- Van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997;50:735-41. https://doi.org/10.1016/S0895-4356(97)00024-3
- Holstein A, Plaschke A, Hammer C, et al. Characteristics and time course of severe glimepiride-versus glibenclamide-induced hypoglycaemia. Eur J Clin Pharmacol 2003;59:91-7. https://doi.org/10.1007/s00228-003-0592-4
- Holstein A, Egberts EH. Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes. Exp Clin Endocrinol Diabetes 2003;111:405-14. https://doi.org/10.1055/s-2003-44287
- El Ghandour S, Azar ST. Dysglycemia associated with quinolones. Prim Care Diabetes 2015;9:168-71. https://doi.org/10.1016/j.pcd.2014.10.006
- Dear Healthcare Professional/Pharmacist Letter. Ministry of Food and Drug Safety, Seoul, Korea. Available from http://www.mfds.go.kr/brd/m_545/view.do?seq=279&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&com-pany_nm=&page=1. Accessed August 14, 2018.
- Schelleman H, Bilker WB, Brensinger CM, et al. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide. Clin Pharmacol Ther 2010;88:214-22. https://doi.org/10.1038/clpt.2010.74
- Andre F, Peter F, Martin C. Systemic side effects of eye drops: a pharmacokinetic perspective. Clin Ophthalmol 2016;10:2433-41. https://doi.org/10.2147/OPTH.S118409
- Lee JW, Woo SY, Park SJ, et al. Clostridium difficile Colitis after Topical Ophthalmic Use of Levofloxacin. Ewha Med J 2013;36(Suppl):S5-S8. https://doi.org/10.12771/emj.2013.36.S.S5
- Actavis. Package leaflet: Information for the patient; Levofloxacin 5mg/ml Eye Drops Solution. Actavis, Barnstaple, EX32 8NS, UK, 2018. Available at https://www.medicines.org.uk/emc/files/pil.7357.pdf. Accessed July 03, 2018.
- Allergan Pharmaceuticals Ireland. PACKAGE LEAFLET: INFORMATION FOR THE USER Exocin: ofloxacin 0.3% w/v eye drops, solution. Allergan Pharmaceuticals Ireland, Westport, Co. Mayo, Ireland, 2018. Available from http://www.hpra.ie/img/uploaded/swedocuments/2132153.PA0148_049_001.ec052f90-b0e7-414f-8476-61ea0b4f5da7.000001Product%20Leaflet%20Approved.131121.pdf. Accessed July 05, 2018.
- Kilbridge PM, Campbell UC, Cozart HB, et al. Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc 2006;13:372-7. https://doi.org/10.1197/jamia.M2069
- Holstein A, Plaschke A, Egberts EH. Incidence and costs of severe hypoglycemia. Diabetes Care 2002;25:2109-10. https://doi.org/10.2337/diacare.25.11.2109
- Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12. https://doi.org/10.2337/diacare.26.6.1902
- Daniele S. Sulfonylureas and their use in clinical practice. Arch Med Sci 2015;11:840-8.
- Vestal RE. Drug use in the elderly: a review of problems and special considerations. Drugs 1978;16:358. https://doi.org/10.2165/00003495-197816040-00004